Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS Combined With rTMS for the Treatment of Negative Symptoms in Patients With Schizophrenia: a Randomized Controlled Trial

NCT05695144 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT05695144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05695144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS Combined With rTMS for the Treatment of Negative Symptoms in Patients With Schizophrenia: a Randomized Controlled Trial
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2022
Completion date
December 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia negative type